Treatment of chronic myelomonocytic leukemia with 5-azacytidine: case reports
{{output}}
Epigenetic therapy with hypomethylating agent (5-azacytidine; AZA) is common in the management of specific subtypes of myelodysplastic syndrome (MDS), but there are only few studies in chronic myelomonocytic leukemia (CMML) patients. In this paper our experien... ...
